Results 211 to 220 of about 11,641 (225)
Some of the next articles are maybe not open access.
Understanding biased agonism at the dopamine D₂ receptor
2017 The phenomenon of “biased agonism” presents an attractive avenue for drug development as it allows the separation of therapeutic effects from side effects mediated by the same target. A prototypical G protein-coupled receptor at which biased agonism has been extensively studied is the dopamine D₂ receptor, an important therapeutic target for current ...openaire +1 more sourceBiased Agonism
2010 Peter J. Tyrer, Mark Slifstein, Joris C. Verster, Kim Fromme, Amee B. Patel, Britta Hahn, Christer Allgulander, A. Claudio Cuello, Giovanni Hernandez, Peter Shizgal, Irwin Lucki, Warren K. Bickel, Darren R. Christensen, Craig A. Erickson, David J. Posey, Kelly Blankenship, Kimberly A. Stigler, Christopher J. McDougle, Verity J. Brown, David S. Tait, Andrea Bari, Gorkem Yararbas, Sakire Pogun, Richard W. Foltin, Harriet de Wit, Daniel Hoyer, Daniel Hoyer, Christer Allgulander, David Nutt, Peter J. Tyrer, Gessica Sala, Lucio Tremolizzo, Carlo Ferrarese, Mark Slifstein, Eric P. Zorrilla, Pietro Cottone, Sarah Parylak, Gorkem Yararbas, Sakire Pogun, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, R. H. Belmaker, Tiffany Thomas, Robert L. Findling, Sheldon Preskorn, Megan M. Dahmen, Jana Lincoln, Helen J. Cassaday, Seiya Miyamoto, Jean-Michel Scherrmann, Jean-Michel Scherrmann, Michael J. Owens, Chase H. Bourke, Martina de Zwaan, Christof Baltes, Thomas Mueggler, Markus Rudin, Mark Slifstein, Mark Slifstein, Debby Van Dam, Peter Paul De Deyn, Joseph H. Friedman, Wiepke Cahn, Heleen B. M. Boos, H. D. Postma, David S. Middlemas, David B. Bylund, Giovanni Hernandez, Peter Shizgal, David C. S. Roberts, Emma Childs, Daniel Hoyer, Seiya Miyamoto, Naheed (Max) Mirza, Lance R. McMahon, Linda Dykstra, Gabriele Fischer, Annemarie Unger, Mohammed Shoaib, David S. Baldwin, W. Wolfgang Fleischhacker +81 moreopenaire +1 more source
